← ANALYSTS · TIPRANKS
Sean McCutcheon · Raymond James
Hits
43%
12 of 28 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+39.7%
Over a year after the rating, TipRanks’ measure
Our companies rated now
8
Buy / hold / sell: 7 / 1 / 0
Upside of the analyst’s targets
+166.9%
Average over 7 current targets, to the last price
The market’s answer to the ratings
+5.3%
Day-0 move against SPY in the rating’s direction, average over 6 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 1on TipRanks 07:20 | XNCRIWMXencor · $1.8B | Assigned | Buy | $46.00 | +101.3% | +3.1%next day −4.1% · 5 days −10.7% | ↗ |
| Aug 27on TipRanks 08:35 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $230 → $248+7.8% | +39.4% | +2.0%next day −5.8% · 5 days −4.9% | ↗ |
| Aug 6on TipRanks Aug 7 03:30 | BDTXIWMBlack Diamond Therapeutics · $100M | Reiterated | Buy | $11.00 | +539.5% | +7.4%next day +1.0% · 5 days +4.0% | ↗ |
| Jul 31on TipRanks 06:38 | FTHFaeth Therapeutics · $517M | Initiated | Buy | $56.00 | +197.9% | −6.2%next day −1.1% · 5 days −14.0% | ↗ |
| May 19on TipRanks 11:20 | RLAYIWMRelay Therapeutics · $3.8B | Reiterated | Buy | $23.00 → $26.00+13.0% | +59.7% | +0.4%next day +6.8% · 5 days +17.3% | ↗ |
| May 8on TipRanks 05:20 | ENGNenGene Holdings · $115M | Reiterated | Buy | $27.00 → $4.00−85.2% | +139.5% | −13.6%next day −0.9% · 5 days +14.5% | ↗ |
| Apr 28on TipRanks 06:40 | CMPXIWMCompass Therapeutics · $158M | Downgrade | Hold | — | — | +3.3%next day −9.2% · 5 days +4.3% | ↗ |
| Feb 24on TipRanks 06:15 | VIRIWMVir Biotechnology · $1.8B | Reiterated | Buy | $12.00 → $19.00+58.3% | +90.8% | +27.0%next day +4.5% · 5 days −5.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗